Multinationals are pushing the Trump administration to deepen the tax break it has already tentatively proposed on $2.6 trillion in profits being held offshore.
David Tepper's Appaloosa Management sold its stake in JCPenney in the first quarter, according to an SEC filing Friday.
With 230 shares of Canada Goose, PETA increased its stock portfolio, which is built on pushing companies to rethink their use of animals.
One highly anticipated piece of tax reform should support stocks in two industries, UBS analysts say.
Apple may have the biggest overall stash, but other companies could also stand to save billions on a corporate tax holiday.
Several components in the IQ 100, including Advanced Micro Devices, General Motors, Pfizer and Micron Technology are getting hit hard today.
Some of the names on the move ahead of the open.
Drugmaker Pfizer reported a 2.7 percent rise in quarterly profit, helped by higher sales of breast cancer drug Ibrance.
U.S. companies are holding $2.6 trillion in cash overseas, according to new research.
In the 2017 CNBC Stock Draft, The Rugters All-Stars choose their second-round draft pick.
Rather than use the money for hiring and capital purchases, companies plowed the cash into buybacks and dividends.
Samsung Bioepis has won regulatory approval for key biosimilar drug, the first time the company's product has been approved for U.S. use.
South Korea's Samsung Bioepis wins U.S. FDA nod for biosimilar of J&J's Remicade.
This Saturday's March for Science is trying hard to be a nonpartisan event, but some may not see it that way.
The bank's global M&A boss dangled the audacious notion that capital markets could fully finance a 12-figure takeover.
CNBC's Meg Tirrell takes a look at the next potential blockbuster drugs. With the "Fast Money" traders.
President Donald Trump plans to revive the hobbled Export-Import Bank of the United States, his office said.
Mylan announced Friday that it is expanding its voluntary EpiPen recall to include units in the United States.
Jim Cramer surveyed the consumer products space to find which stocks could satiate your portfolio’s appetite.
Jim Cramer rattled off his take on caller favorite stocks, including defense contractor Raytheon.